Jazz Pharmaceuticals JAZZ Vyxeos — Revenue from Contract with Customer, Excluding Assessed Tax
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's vyxeos — revenue from contract with customer, excluding assessed tax.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's vyxeos — revenue from contract with customer, excluding assessed tax?
- Jazz Pharmaceuticals (JAZZ) reported vyxeos — revenue from contract with customer, excluding assessed tax of $26.6M in Q1 2026.
- How has Jazz Pharmaceuticals's vyxeos — revenue from contract with customer, excluding assessed tax changed year-over-year?
- Jazz Pharmaceuticals's vyxeos — revenue from contract with customer, excluding assessed tax decreased by 9.8% year-over-year, from $29.5M to $26.6M.
- What is the long-term trend for Jazz Pharmaceuticals's vyxeos — revenue from contract with customer, excluding assessed tax?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's vyxeos — revenue from contract with customer, excluding assessed tax has grown at a 2.3% compound annual growth rate (CAGR), from $134.06M to $146.67M.
- What does vyxeos — revenue from contract with customer, excluding assessed tax mean?
- The total net sales revenue generated by the Vyxeos oncology product line after accounting for all commercial adjustments.
- How do you interpret vyxeos — revenue from contract with customer, excluding assessed tax?
- An increase indicates growing market penetration or expanded clinical utilization of the therapy, while a decrease may signal increased competition, patent expiration, or shifts in standard-of-care treatment protocols.
- How does vyxeos — revenue from contract with customer, excluding assessed tax compare across companies?
- Comparable to net product revenue metrics reported by other biopharmaceutical companies for specific oncology assets or specialty drug franchises.